Home » QRxPharma Comes Good on Promise
QRxPharma Comes Good on Promise
In a rare achievement for the biotech sector, QRxPharma, the pain-drug developer, has come good on its promise of an alliance with a deep-pocketed partner — and within its nominated December-end time frame.
The Australian
The Australian
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May